ATU to Early Access: A New Framework to Bring Patients Closer to Innovation

How do we speed up access to breakthrough treatments while keeping patients safe?

Join us for an evening that puts this critical question in the spotlight.

💬 First, Voisin Consulting Life Sciences experts Adeline Darchy (Senior Director, Clinical Research) and Gabrielle Nayroles (Director, Market Access) will kick things off with a keynote speech on accelerated access to innovative therapies.

🗫 Then, our dynamic panelists will unpack:

• the conditions for access,
• the safety challenges, and
• the balance between speed and rigor

in making these novel treatments available to the patients who need them.

🍷 The conversation will continue over cocktails. Network with the panelists, VCLS experts, healthtech innovators, and industry leaders who are redefining the path from bench to bedside.